Product NDC: | 24478-210 |
Proprietary Name: | Quillivant |
Non Proprietary Name: | METHYLPHENIDATE HYDROCHLORIDE |
Active Ingredient(s): | 900 mg/180mL & nbsp; METHYLPHENIDATE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24478-210 |
Labeler Name: | NextWave Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202100 |
Marketing Category: | NDA |
Start Marketing Date: | 20121001 |
Package NDC: | 24478-210-30 |
Package Description: | 180 mL in 1 BOTTLE (24478-210-30) |
NDC Code | 24478-210-30 |
Proprietary Name | Quillivant |
Package Description | 180 mL in 1 BOTTLE (24478-210-30) |
Product NDC | 24478-210 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METHYLPHENIDATE HYDROCHLORIDE |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20121001 |
Marketing Category Name | NDA |
Labeler Name | NextWave Pharmaceuticals, Inc. |
Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
Strength Number | 900 |
Strength Unit | mg/180mL |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE] |